PyrAmes Inc.


PyrAmes is a digital health company focused on transforming healthcare delivery through advanced sensor measurement. The company is developing a proprietary platform for continuous, accurate, wireless, and non-invasive blood pressure monitoring for patients of all ages, from newborns to seniors. PyrAmes aims to make blood pressure monitoring easy, low-cost, unobtrusive, and painless, ultimately improving patient outcomes.

PyrAmes

PyrAmes Inc.

21730 Stevens Creek Blvd, Suite 201A, Cupertino, CA 95014

PyrAmes Inc. is currently seeking investment

PyrAmes Inc. is seeking a series-b investment in the range of 5m-20m

All Investment-seeking Members

What We Do

A non-invasive, continuous, wireless blood pressure monitoring device designed for neonatal patients, providing essential clinical information for critically ill infants.

An adult inpatient and emergency care platform for continuous non-invasive blood pressure monitoring.

A home monitoring system for diagnostics, treatment validation, and medical management, designed to provide continuous blood pressure monitoring for outpatient care.


FDA Regulated Medical Devices

Battlefield Resuscitation


Key People

Xina Quan, PhD

Co-founder & CEO

LinkedIn

Will Sutherland, PE

Chief Operating Officer

LinkedIn

Junjun Liu, PhD

Senior Data Scientist

LinkedIn

Thomas Roxlo, PhD

Senior Data Scientist

Art Muir, MBA

Product Manager

LinkedIn

Weyland Leong

Senior Product Engineer

LinkedIn

News & Updates

PyrAmes was selected as the best business pitch by a panel of expert judges at the American Heart Association’s annual Health Tech Competition during Scientific Sessions 2023.

PyrAmes CEO Xina Quan, Ph.D., was recognized as the sixth winner of TEAMFund's Annual Global Health Innovator Award, highlighting her contributions as a female founder in health technology.

PyrAmes announced it has received FDA 510(k) clearance for its Boppli® platform, enabling continuous and non-invasive blood pressure monitoring for critically-ill infants.